New Key Statistics Module, Z-Score and F-Score
SHSE:603439 Key Ratios
Market Cap ¥ M | 6,320.07 |
Enterprise Value ¥ M | 6,118.82 |
P/E(ttm) | 21.42 |
PE Ratio without NRI | 21.24 |
Forward PE Ratio | -- |
Price/Book | 4.10 |
Price/Sales | 3.71 |
Price/Free Cash Flow | 30.90 |
Price/Owner Earnings | 26.10 |
Payout Ratio % | 0.14 |
Revenue (TTM) ¥ M | 1,708.00 |
EPS (TTM) ¥ | 0.72 |
Beneish M-Score | -2.09 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 17.90 |
y-y EBITDA Growth Rate % | 25.10 |
EV-to-EBIT | 18.06 |
EV-to-EBITDA | 18.06 |
PEG | 1.19 |
Shares Outstanding M | 409.86 |
Net Margin (%) | 17.20 |
Operating Margin % | 17.28 |
Pre-tax Margin (%) | 19.80 |
Quick Ratio | 1.67 |
Current Ratio | 1.96 |
ROA % (ttm) | 12.61 |
ROE % (ttm) | 21.05 |
ROIC % (ttm) | 18.67 |
Dividend Yield % | 0.66 |
Altman Z-Score | 4.88 |
SHSE:603439 Number of Guru Trades
SHSE:603439 Volume of Guru Trades
Gurus Latest Trades with SHSE:603439
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603439 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guizhou Sanli Pharmaceutical Co Ltd Insider Transactions
No Available Data